299. Cystic fibrosis Clinical trials / Disease details
Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00221546 (ClinicalTrials.gov) | September 2007 | 12/9/2005 | Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis | Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis | Cystic Fibrosis | Drug: Giving DHA-rich supplement | University Hospital, Ghent | Belgian Society against Cystic Fibrosis | Completed | 6 Years | N/A | Both | 17 | Phase 2 | Belgium |